Skip to content

Mansi Oberoi

NPI 1386107910ActiveIndividual· Internal Medicine, Advanced Heart Failure and Transplant Cardiology· New Orleans, LA

Internal Medicine, Advanced Heart Failure and Transplant Cardiology in New Orleans, Louisiana, licensed in LA, with an NPI issued in April 2019. Part D covered 12 prescriptions written in 2024. Abbott Laboratories was the largest of 2 companies reporting payments in 2025, $9,234 in all, mostly grants.

Overview

NPI1386107910
StatusActive
Entity typeIndividual
Sole proprietorNo
NPI issuedApr 10, 2019
Last updated in NPPESSep 4, 2026
Certified by providerSep 4, 2026

Specialties and licenses

About license numbers in NPPES

Exclusion screening

ListResultDetails
HHS-OIG LEIE · Oct 9, 2026No matchChecked by NPI and by name + state
North Carolina Medicaid · Nov 10, 2026No match—
New York OMIG · Nov 10, 2026No match—
Ohio Medicaid · Nov 10, 2026No match—
Pennsylvania Medicheck · Nov 10, 2026No match—
Washington HCA · Nov 10, 2026No match—

Official OIG search · How matching works ·Bulk check a roster

Medicare

Enrollment (PECOS)Enrolled Order and Referring Only - Internal Medicine (SD)

Part D prescriptions in 2024

Prescriptions (claims)12 · 15 30-day fills
Total drug cost$892.86

Medicare sources and data years

Industry payments (Open Payments)

  • 2025$9,234 · 41 payments from 2 companies
  • 2024$2,040 · 19 payments from 2 companies

Top paying companies in 2025

CompanyAmountPayments
Abbott Laboratories$9,13239
Astrazeneca Pharmaceuticals LP$102.052

What the 2025 payments were for

  • Grant$4,500 · 1 payment
  • Travel and Lodging$3,840 · 16 payments
  • Food and Beverage$894.45 · 24 payments

Receiving payments does not imply wrongdoing. What Open Payments covers ·original records

Other Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in New Orleans

All Internal Medicine, Advanced Heart Failure and Transplant Cardiology providers in Louisiana →